Medical information specialists to share relevant information such as new study results and safety updates

Exchange questions and answers about our medicines and their uses

An important forum for feedback from health care professionals about their experiences using our medicines.

Characteristics of the information shared: Pfizer is committed to ensuring the information shared by our representatives:

Is in line with Food and Drug Administration (FDA)-approved labeling

Fairly balances the benefit and risk information relating to any Pfizer product discussed

How patients benefit

Patients are more likely to have better-informed health care providers: Physicians who have up-to-date information on available medicines may make more informed treatment decisions.

How health care professionals benefit

Health care professionals have an efficient opportunity to learn the latest information: Doctors must balance time spent keeping up with new information about diseases and medicines with seeing and providing care to patients.

Conducting product information exchanges in the health care professional's office enables him or her to learn more about our medicines without taking valuable time away from patient care.

How Pfizer benefits

We have an opportunity to share information about our products and clinical research: Informing health care providers about our medicines and directing them to the results of new studies is a key part of how Pfizer tells health care providers about the latest scientific findings on the use of our products.

We learn more about how our medicines are being used and what questions people have: These in-office meetings also enable Pfizer to hear about health care professionals' firsthand experiences with our medicines and can help lead to improvements in their design and use.